CRISPR Therapeutics AG ; Open. $ Previous Close ; YTD Change. %. 12 Month Change ; Day Range · 52 Wk Range. View research reports from Argus and trade ideas from Trading Central to understand future stock performances and find high performing trade ideas. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect. The 16 analysts with month price forecasts for CRSP stock have an average target of , with a low estimate of 30 and a high estimate of The average. The 65 analysts offering price forecasts for CRISPR Therapeutics have a median target of , with a high estimate of and a low estimate of
According to the latest long-term forecast, CRISPR Therapeutics price will hit $55 by the end of and then $80 by the end of CRISPR Therapeutics will. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. The forecasts range from a low of $ to a high of $ The average price target represents an increase of % from the last closing price of $ CRISPR Therapeutics stock price forecast on Monday, September, dollars, maximum , minimum CRISPR Therapeutics stock prediction on Tuesday. The current price of CRSP is USD — it has decreased by −% in the past 24 hours. Watch CRISPR Therapeutics AG stock price performance more closely on. According to analysts, CRSP price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. View CRISPR Therapeutics AG CRSP stock quote prices, financial information, real-time forecasts, and company news from CNN. Track CRISPR Therapeutics AG (CRSP) Stock Price, Quote, latest community messages, chart, news and other stock related information. CRISPR Therapeutics AG (CRSP) stock price prediction is USD. The CRISPR Therapeutics AG stock forecast is USD for CRISPR Therapeutics AG CRSP:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date02/22/24 · 52 Week Low. Bid Price and Ask Price. The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is.
On average, Wall Street analysts predict that Crispr Therapeutics Ag's share price could reach $ by Aug 12, The average Crispr Therapeutics Ag stock. % · Previous Close · Open · Bid x · Ask x · Day's Range - · 52 Week Range - · Volume , · Avg. Down Nearly 50% From Its Week High, Is CRISPR Therapeutics a Steal of a Deal? Is the potential upside for CRISPR Therapeutics too massive to ignore? 35 analysts offering month price forecasts for Crispr Therapeutics Ag (CRSP) have a share price target of $ This median of share price forecast. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ CRSP will report FY earnings on 02/18/ Yearly Estimates. CRSP's current price target is $ Learn why top analysts are making this stock forecast for CRISPR Therapeutics at MarketBeat. We maintain our positive long-term outlook and $ fair value estimate. We view the stock as very undervalued, currently trading in 5-star territory. Crispr. What was Crispr Therapeutics AG's price range in the past 12 months? Crispr Therapeutics AG lowest stock price was $ and its highest was $ in the past. Based on analysts offering 12 month price targets for CRSP in the last 3 months. The average price target is $74 with a high estimate of $ and a low estimate.
Analysts average stock forecasts to be materialized ratio is % with an average time for these price targets to be met of days. Highest price target. CRISPR Therapeutics AG ; Next Fiscal Year Estimate, ; Median PE on Next FY Estimate, N/A ; High, $ ; Median, $ ; Low, $ The CRISPR Therapeutics AG stock prediction for is currently $ , assuming that CRISPR Therapeutics AG shares will continue growing at the average. CRISPR Therapeutics AG has a consensus price target of $ based on the ratings of 28 analysts. The high is $ issued by SVB Leerink on August 8, A high-level overview of CRISPR Therapeutics AG (CRSP) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and.
View CRISPR Therapeutics (CRSP) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Despite a slight underperformance compared to the market, the +% rise in CRSP's stock price signifies sustained investor confidence in the company's. AI Munafa prediction value: 69 as on Wed 31 July · How is AI Munafa prediction value determined? · Stock price target for CRISPR Therapeutics AG CRSP are. Analysts' recommendations: CRISPR Therapeutics AG · Truist Adjusts Price Target on CRISPR Therapeutics to $ From $, Maintains Buy Rating · Morgan Stanley. The current CRISPR Therapeutics AG [CRSP] share price is $ The Score for CRSP is 42, which is 16% below its historic median score of 50, and infers higher.
How Much Can I Make From Selling Plasma | Best Auto Insurance In New Hampshire